OSL said its latest milestone reflects “strong recognition” of its digital asset business model.
You might also be interested in reading Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth.
OSL said its latest milestone reflects “strong recognition” of its digital asset business model.
You might also be interested in reading Amgen in charts: Key drug sales drop in Q2, but Otezla sees continued growth.